中华医学杂志(英文版)Issue(11):1931-1935,5.DOI:10.3760/cma.j.issn.0366-6999.2012.11.017
Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients
Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients
摘要
Abstract
Background The pharmacokinetics of zidovudine (AZT) are possibly influenced by weight,age,sex,liver and renal functions,severity of disease,and ethnicity.Currently,little information is available on the steady-state pharmacokinetics of AZT in Chinese HIV-infected patients.The current study aimed to characterize the steady-state pharmacokinetics of AZT in a Chinese set-up.Methods Eleven Chinese HIV-infected patients were involved in the steady-state pharmacokinetic study.In total,300 mg of AZT,as a part of combination therapy,was given to patients,and serial blood samples were collected for 12 hours.The samples were measured by a high-performance liquid chromatography (HPLC) assay,and the results were analyzed by both the non-compartment model and the one-compartment model.Results The Cmax of AZT in Chinese patients was higher than that in non-Asian patients.The half-life of AZT,analyzed by the non-compartment model (P=0.02),in male patients ((1.02±0.22) hours) was shorter than that of AZT in female patients ((1.55±0.29) hours).The AZT clearance,analyzed by the one-compartment model (P=0.045),in male patients ((262.60±28.13) L/h) was higher than that in female patients ((195.85±60.51 ) L/h).Conclusion The present study provides valuable information for the clinical practice of AZT-based highly active antiretroviral therapy in a Chinese set-up.关键词
human immunodeficiency virus/steady-state/pharmacokinetics/zidovudine/Chinese patientsKey words
human immunodeficiency virus/steady-state/pharmacokinetics/zidovudine/Chinese patients引用本文复制引用
LIU Li-feng,WANG Lu,FU Qiang,ZHU Zhu,XIE Jing,HAN Yang,LIU Zheng-yin,YE Min,LI Tai-sheng..Steady-state pharmacokinetics of zidovudine in Chinese HIV-infected patients[J].中华医学杂志(英文版),2012,(11):1931-1935,5.基金项目
This study was supported by the grants from the National Key Technologies R&D Program for the 11th Five-year Plan (No.2008ZX10001-006) and the National Natural Science Foundation of China (No.81071372). (No.2008ZX10001-006)